Home
>
National Drug Code (NDC)
>
Egrifta
Egrifta - 44087-2011-2 - (tesamorelin)
Drug Information of Egrifta
| Product NDC: | 44087-2011 |
| Proprietary Name: | Egrifta |
| Non Proprietary Name: | tesamorelin |
| Active Ingredient(s): | & nbsp; tesamorelin |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Egrifta
| Product NDC: | 44087-2011 |
| Labeler Name: | EMD Serono, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022505 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120905 |
Package Information of Egrifta
| Package NDC: | 44087-2011-2 |
| Package Description: | 1 KIT in 1 BOX (44087-2011-2) * 2 mL in 1 VIAL * 10 mL in 1 BOTTLE (0409-4887-34) |
NDC Information of Egrifta
| NDC Code | 44087-2011-2 |
| Proprietary Name | Egrifta |
| Package Description | 1 KIT in 1 BOX (44087-2011-2) * 2 mL in 1 VIAL * 10 mL in 1 BOTTLE (0409-4887-34) |
| Product NDC | 44087-2011 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tesamorelin |
| Dosage Form Name | KIT |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20120905 |
| Marketing Category Name | NDA |
| Labeler Name | EMD Serono, Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
